Search

Search Constraints

You searched for: Author/Creator Popat, S

Search Results

1. 1384PDPembrolizumab in performance status 2 patients with non-small cell lung cancer (NSCLC): Results of the PePS2 trial. (23rd October 2018)

3. 1465PPhase I dose escalation of pembrolizumab given concurrently with palliative thoracic radiotherapy (RT) for NSCLC. (23rd October 2018)

4. 16 Integrated oncology and palliative care: analysis of a new 'triggers' service for lung cancer patients. Issue Volume 9: Issue (2019)Supplement 1 (March 2019)

6. Contribution of the MHC region to the familial risk of coeliac disease. Issue 9 (1st September 1999)

7. Exon 3 β-catenin mutations are specifically associated with colorectal carcinomas in hereditary non-polyposis colorectal cancer syndrome. (11th January 2005)

8. Genome screening of coeliac disease. Issue 5 (1st May 2002)

9. Immune checkpoint inhibitors for patients with advanced lung cancer and oncogenic driver alterations: results from the IMMUNOTARGET registry. (24th May 2019)

10. LBA1Brigatinib vs crizotinib in patients with ALK inhibitor-naive advanced ALK+ NSCLC: Updated results from the phase III ALTA-1L trial. (24th November 2019)